Literature DB >> 10793924

[Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad)].

Y Tourtelier1, A Dabadie, I Tron, J L Alexandre, M Robaskiewicz, E Cruchant, J A Seyrig, D Heresbach, J F Bretagne.   

Abstract

BACKGROUND: The aim of this work was to determine in Brittany the incidence and main clinical pattern of inflammatory bowel disease (IBD) occurring during childhood. These data are compared to the previous epidemiologic data available from the Northern France registry or around the world.
METHODS: Private and public Brittany gastroenterologists (2,836,418 inhabitants including 618,049 children under 17 years of age) referred all patients consulting for inflammatory bowel disease from January 1994 to December 1997. An interviewer-practitioner completed at the gastroenterologist's office a standard questionnaire for each patient. Each case was independently reviewed by four experts in a blind manner and made a final diagnosis of Crohn's disease (CD), ulcerative colitis (UC), or ulcerative proctitis and acute colitis (onset of symptoms < 6 weeks) or unclassified chronic colitis.
RESULTS: Among 1,309 cases recorded, 88 were under 17 years of age (6.7%): 43 (49%) had CD (including three possible cases), 14 (16%) had UC (including three proctitis), 24 (27%) acute colitis and 7 (8%) unclassified chronic colitis. The crude mean annual incidence (per 100,000 children) based on definite and probable cases only was 2.5 for IBD, 1.6 for CD and 0.57 for UC, without variation between 1994 and 1997. The male/female ratio was 2.3 for CD and 1.3 for UC. The mean time between onset of disease and diagnosis was equal to 7.2 and 8.6 months for CD and UC respectively (median: 3 and 5 months). A familial history of IBD was present in 5 cases (8%). In CD, the small and large bowel were involved in 58% of patients, whereas an isolated involvement of small or large bowel occurred in 15% and 23% of cases. Among the 14 UC, there were three proctitis and four pancolitis. Among 43 CD, a granuloma was present in 48% of cases.
CONCLUSIONS: In Brittany the incidence of CD and UC in childhood was similar to the published data from Northern France. Clinical presentation and symptoms were not different. However, the rate of acute colitis was higher and the accurate incidence of IBD could be underestimated, requiring a follow-up to classify these cases.

Entities:  

Mesh:

Year:  2000        PMID: 10793924     DOI: 10.1016/s0929-693x(00)88832-6

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  4 in total

1.  Early-onset versus late-onset Crohn's disease: An Italian cohort study.

Authors:  Laura Cantoro; Marco Vincenzo Lenti; Rita Monterubbianesi; Michele Cicala; Diana Giannarelli; Claudio Papi; Anna Kohn; Antonio Di Sabatino
Journal:  United European Gastroenterol J       Date:  2019-06-19       Impact factor: 4.623

2.  Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center.

Authors:  Konstantina Dimakou; Ioanna Pachoula; Ioanna Panayotou; Kalliopi Stefanaki; Irini Orfanou; Evagelia Lagona; Eleftheria Roma-Giannikou; George Chouliaras
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

3.  Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry.

Authors:  Ivana Kern; Olaf Schoffer; Wieland Kiess; Jobst Henker; Martin W Laaß; Ulf Winkler; Jürgen Quietzsch; Olaf Wenzel; Marlen Zurek; Katrin Büttner; Peter Fischer; Jan de Laffolie; Ulf Manuwald; Thoralf Stange; Ronny Zenker; Jens Weidner; Klaus-Peter Zimmer; Hildebrand Kunath; Joachim Kugler; Thomas Richter; Ulrike Rothe
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

Review 4.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.